Delta-Fly Pharmaの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/04/08 | 1,273 | 1,273 | 1,205 | 1,263 | -9 | -0.7% | 196,800 |
2021/04/07 | 1,292 | 1,330 | 1,271 | 1,272 | -41 | -3.1% | 148,700 |
2021/04/06 | 1,298 | 1,314 | 1,273 | 1,313 | -7 | -0.5% | 136,100 |
2021/04/05 | 1,331 | 1,346 | 1,294 | 1,320 | +1 | +0.1% | 118,000 |
2021/04/02 | 1,405 | 1,405 | 1,302 | 1,319 | -88 | -6.3% | 338,500 |
2021/04/01 | 1,382 | 1,409 | 1,364 | 1,407 | +22 | +1.6% | 193,200 |
2021/03/31 | 1,330 | 1,431 | 1,302 | 1,385 | +63 | +4.8% | 321,800 |
2021/03/30 | 1,294 | 1,343 | 1,272 | 1,322 | +44 | +3.4% | 219,100 |
2021/03/29 | 1,368 | 1,370 | 1,256 | 1,278 | -72 | -5.3% | 384,100 |
2021/03/26 | 1,264 | 1,358 | 1,263 | 1,350 | +86 | +6.8% | 261,400 |
2021/03/25 | 1,380 | 1,380 | 1,260 | 1,264 | -122 | -8.8% | 434,100 |
2021/03/24 | 1,327 | 1,407 | 1,288 | 1,386 | +29 | +2.1% | 407,300 |
2021/03/23 | 1,410 | 1,430 | 1,345 | 1,357 | -39 | -2.8% | 287,300 |
2021/03/22 | 1,385 | 1,448 | 1,360 | 1,396 | +25 | +1.8% | 398,900 |
2021/03/19 | 1,251 | 1,385 | 1,242 | 1,371 | +111 | +8.8% | 333,900 |
2021/03/18 | 1,310 | 1,335 | 1,236 | 1,260 | -13 | -1% | 257,400 |
2021/03/17 | 1,235 | 1,312 | 1,210 | 1,273 | +24 | +1.9% | 331,900 |
2021/03/16 | 1,146 | 1,254 | 1,135 | 1,249 | +104 | +9.1% | 165,900 |
2021/03/15 | 1,130 | 1,149 | 1,120 | 1,145 | +21 | +1.9% | 53,300 |
2021/03/12 | 1,116 | 1,125 | 1,096 | 1,124 | +18 | +1.6% | 52,800 |
2021/03/11 | 1,100 | 1,111 | 1,073 | 1,106 | +16 | +1.5% | 40,700 |
2021/03/10 | 1,070 | 1,100 | 1,070 | 1,090 | +20 | +1.9% | 65,300 |
2021/03/09 | 1,054 | 1,078 | 1,026 | 1,070 | +22 | +2.1% | 69,500 |
2021/03/08 | 1,082 | 1,102 | 1,040 | 1,048 | -19 | -1.8% | 86,300 |
2021/03/05 | 1,090 | 1,099 | 1,012 | 1,067 | -36 | -3.3% | 186,800 |
2021/03/04 | 1,138 | 1,151 | 1,087 | 1,103 | -35 | -3.1% | 112,400 |
2021/03/03 | 1,151 | 1,157 | 1,132 | 1,138 | -3 | -0.3% | 44,300 |
2021/03/02 | 1,179 | 1,195 | 1,126 | 1,141 | -24 | -2.1% | 92,300 |
2021/03/01 | 1,169 | 1,183 | 1,137 | 1,165 | +12 | +1% | 99,400 |
2021/02/26 | 1,132 | 1,175 | 1,105 | 1,153 | +13 | +1.1% | 108,100 |
2021/02/25 | 1,143 | 1,154 | 1,117 | 1,140 | +27 | +2.4% | 47,900 |
2021/02/24 | 1,155 | 1,175 | 1,113 | 1,113 | -52 | -4.5% | 75,700 |
2021/02/22 | 1,110 | 1,172 | 1,103 | 1,165 | +51 | +4.6% | 71,200 |
2021/02/19 | 1,126 | 1,134 | 1,081 | 1,114 | -12 | -1.1% | 66,200 |
2021/02/18 | 1,158 | 1,166 | 1,123 | 1,126 | -27 | -2.3% | 56,900 |
2021/02/17 | 1,110 | 1,157 | 1,110 | 1,153 | +33 | +2.9% | 60,500 |
2021/02/16 | 1,100 | 1,134 | 1,090 | 1,120 | +16 | +1.4% | 77,800 |
2021/02/15 | 1,110 | 1,116 | 1,060 | 1,104 | ±0 | ±0% | 117,500 |
2021/02/12 | 1,120 | 1,123 | 1,090 | 1,104 | -25 | -2.2% | 97,900 |
2021/02/10 | 1,127 | 1,138 | 1,115 | 1,129 | -18 | -1.6% | 95,400 |
2021/02/09 | 1,180 | 1,209 | 1,135 | 1,147 | -3 | -0.3% | 273,000 |
2021/02/08 | 1,181 | 1,181 | 1,130 | 1,150 | -32 | -2.7% | 108,500 |
2021/02/05 | 1,165 | 1,184 | 1,141 | 1,182 | +16 | +1.4% | 93,500 |
2021/02/04 | 1,150 | 1,168 | 1,126 | 1,166 | +22 | +1.9% | 78,300 |
2021/02/03 | 1,140 | 1,160 | 1,112 | 1,144 | +16 | +1.4% | 87,700 |
2021/02/02 | 1,108 | 1,134 | 1,076 | 1,128 | +30 | +2.7% | 88,800 |
2021/02/01 | 1,103 | 1,108 | 1,057 | 1,098 | -21 | -1.9% | 108,600 |
2021/01/29 | 1,163 | 1,177 | 1,104 | 1,119 | -41 | -3.5% | 169,700 |
2021/01/28 | 1,162 | 1,185 | 1,149 | 1,160 | -32 | -2.7% | 90,000 |
2021/01/27 | 1,211 | 1,254 | 1,180 | 1,192 | -19 | -1.6% | 110,500 |
751~
800
件表示中 / 1354件
類似銘柄と比較する
現在ご覧いただいている「DELTA-P」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
DELTA-P | 73,900円 | - | - | 0.00% | - | 15.17倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
カイオム | 12,300円 | +2.6% | - | 0.00% | - | 6.02倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
ノイルイミューン | 15,800円 | -5.1% | - | 0.00% | - | 1.20倍 |
|
独自技術用いたCAR-T細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
サイフューズ | 70,600円 | +891.8% | - | 0.00% | - | 1.75倍 |
|
バイオ3Dプリンタを開発、自家細胞製品の製造受託も。臓器など再生医療等製品を臨床開発中 |
カイノス | 120,800円 | +5.6% | -0.4% | 2.65% | 8.93倍 | 0.86倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
市場注目の銘柄
チャート関連のコラム